Creating an optimised antigen-specific immunotherapy for type 1 diabetes

Project Details

Short titleCreating an optimised antigen-specific immunotherapy for type 1 diabetes
StatusActive
Effective start/end date1/05/2330/04/26

Funding

  • HELMSLEY TRUST